Phillip Jennings

Discussions on policies, programs and regulations related to the energy efficiency, decarbonization, and competitiveness of the mining and metal industry. Discussions on mining and regional economic development, including mine closures, as well as policies on conservation, nature-based solutions, and marine protected areas. Discussions on enhancing Canada’s Mining and Metals sector competitiveness through fiscal and tax policies, supporting new technologies, innovation, and advanced manufacturing and national security. Discussions on existing policies and regulations that impact efficient operations of port, rail, and transportation and trade corridors; and development of enabling infrastructure to support competitiveness of mining projects in remote regions of Canada. Discussions on policies and programs aimed at enhancing access to energy to support project development. Discussions on regulatory reforms for major projects and their effects on the mining and metal industry. Discussions on labour measures, skilled labour access, supply chain challenges, and the implementation of legislation and regulations related to this topic. Discussions on critical minerals including federal programs and policies, sector competitiveness, infrastructure, and project updates Trade-related matters, including policies, tariffs, international agreements.

Opportunities for the Canadian Light Utility Vehicle (LUV) procurement using Canadian made steel to support domestic jobs and manufacturing. New opportunities for Canadian defence procurements and other buy Canadian opportunities such as infrastructure and transportation. Potential new policies, regulations, or international agreements impacting Canada’s international trade framework, with implications for the steel industry. Federal government priorities and policies related to the international trade of steel and improve the competitiveness of the domestic steel industry. Support measures for steel industry and workers based on domestic economic conditions, increased tariffs, and ongoing global trade issues.

Transport Canada Rail Program related to support for logistics to ship product to Western Canada. Air Quality regulations and compliance pertaining to the ongoing operations of Coke Plants as part of integrated steelmaking. CUSMA review, USA Tariffs and Internal trade Strategic Response Fund (SRF) Entry Visa's to facilitate investment discussions Buy Canada Initiative SIF Net Zero accelerator Fund Requesting that Consular Offices assist in facilitating employees' return to Canada. Communicating with the Government of Canada about Ballast Water Control and Management Regulations SOR/2011-237, more specifically management of ballast on vessels. Communicating with government officials about the Strategic Innovation Fund (SIF) for Canada's steel sector and Finance Canada about the Investment Tax Credits for investment in equipment to reduce carbon intensity. Communicating with government officials about the imposition of countermeasures (surtaxes) on steel imports from the United States Communicating with government officials about the imposition of national security tariffs on steel exports to the United States. Communicating with government officials about the Federal carbon Pricing backstop, specifically the Output-Based Pricing System (OBPS) Communicating with government officials about the North American Free Trade Agreement (NAFTA), specifically those provisions related to the steel sector.

Promote regulatory harmonization or recognition with the the United States, that would allow for the importation of Heavy Trucks from The United States into Canada for the 2027 model year. Increasing or maintaining limits on automotive technician under temporary foreign workers rules Increase enforcement action against organized crime involvd in auto theft Review the 15 year age limit exclusion for the prescribed classes of vehicles that can be imported without needing to comply with Canada Motor Vehicle Safety Standards (CMVSS). The Canadian Automobile Dealers Association is seeking an extension of that exclusion to 25 years. REGULATIONS AMENDING CERTAIN REGULATIONS MADE UNDER THE PROCEEDS OF CRIME (MONEY LAUNDERING) AND TERRORIST FINANCING ACT (2008-1) PROCEEDS OF CRIME (MONEY LAUNDERING) AND TERRORIST FINANCING SUSPICIOUS TRANSACTION REPORTING REGULATIONS. Communicating with government officials regarding issues related to the tracking of cash transactions at retail locations Promote free trade in automotive sector in North American Free Trade Agreement Promote Canadian vehicle fuel economy standards that are harmonized within North American Market. Potential new federal regulations requiring mandatory vehicle fuel economy labels Oppose a luxury tax on cars over $100,000 Maintain Bank Act provisions that restrict chartered banks' ability to enter the leasing market.

Advocacy related to university engagement in Canadian priorities in artificial intelligence, data systems and related computing science and energy subjects, including but not limited to specific calls for proposals. Advocacy for university initiatives related to Canadian priorities across the defence spectrum, including initiatives relevant to both Defence and Veterans' Affairs, among other federal departments. Advocacy to enhance support for university research mobilization and commercialization activities. Research security, with respect to international research partnerships Discussions with Innovation, Science and Economic Development Canada and other relevant departments and agencies regarding the role of universities in supporting federal innovation initiatives, policies and programs. Discussions regarding research and development initiatives and federal support related to energy and environment, and climate change research, innovation, commercialization, talent and knowledge mobilization. Discussions regarding official language funding amounts and mechanisms. Discussions about the Copyright Act and details of its implementation in a post-secondary setting. Advocacy to secure support in the budget for post-secondary education, research, innovation, and science and technology. Advocacy to secure federal support to develop and upgrade university infrastructure, including but not limited to research and learning facilities, digital infrastructure, and transit infrastructure. Advocacy to increase support for university research, including research funding and granting programs administered by the tri-agencies (SSHRC, NSERC, CIHR) and other departments and agencies. Advocacy to improve immigration policies and programs for prospective and current university students, faculty, and staff. Advocacy to ensure that proposals to develop or amend federal legislation, regulations, policies or programs that directly or indirectly impact the post-secondary system reflect the needs of universities and support our research and education mission. Advocacy to enhance student supports, including but no limited to Canada Student Grants and Loans, the Canada Graduate Scholarship Program, supports for Indigenous students, and work-integrated learning programs. Advocacy to advance Canadian leadership in priority areas to support world class research, talent attraction and retention, and knowledge mobilization. Advocacy related to reconciliation efforts, including but not limited to the Truth and Reconciliation Commission's Calls to Action

Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products.

Communications regarding opportunities to speed patient access to live-saving medicines on publicly-funded drug formularies in Canada by reducing red tape. Innovation, Science and Economic Development (ISED)'s Health Emergency Readiness program, insofar as it pertains to growth and development of the life sciences industry in Canada. Communication regarding free trade agreements as they relate to the biopharmaceutical industry. The pan Canadian Pharmaceutical Alliance (pCPA) with respect to public formulary listing of new medicines, insofar as the federal government is a participating jurisdiction and holds a seat on the Board of Directors. Public Health Agency of Canada, regarding the federal response to the hepatitis C virus. Patented Medicine Prices Review Board (PMPRB) Guidelines with regard to prices charged by Rights Holders for patented medicines sold in Canada. Federal Government Non Insured Health Benefits program with respect to reimbursement of a prescription medicine and changes in type of reimbursement Engagement with Health Canada’s Regulatory Operations & Enforcement branch regarding supply chain resilience & integrity; mitigating and alleviating drug shortages. Communications with Heath Canada regarding modernization of the medical devices regulatory framework. Communications with Health Canada regarding the evolution of the regulatory framework to address advanced therapeutic products. Communications with Health Canada regarding the application of its nitrosamine guidelines. Communications with Health Canada regarding modernization of clinical trials regulations, including diversity and inclusivity of clinical trials. Communications with Health Canada regarding guidelines for pediatric action plans. Communications regarding the value assessment of new medicines by Canada's Drug Agency (CDA) and the design of proposed new work streams, insofar as the federal government is a funder and holds a seat on the Board of Directors. Communications regarding the design and implementation of the federal Drugs for Rare Diseases strategy. Communications regarding national pharmacare legislation, regulations, policies or programs. Communications regarding intellectual property protection of prescription drugs, including the Patent Act, the Patented Medicines Regulations, the Patented Medicine Notice of Compliance (PMNOC) Regulations, the Patent Term Adjustment regime and Health Canada’s Data Protection regime. Communications regarding Health Canada's Regulatory Innovation Agenda regarding proposed regulatory amendments and guidelines to enable agile licensing of drugs and medical devices. Communications regarding access to and approval of medicines addressing the growing public health threat of antimicrobial resistance.

Promotion de l'avancement de la cybersécurité dans les transports publiques. Advocating for the rail sector in relation to changes to clean technology investment tax credit. Recherche de financement via le programme de fonds stratégiques pour l'innovation (FSI) afin d'offrir des solutions ferroviaires innovantes. Establishment or modification of appropriate regulations regarding trade. Research and Development funding for advanced manufacturing and developing mobility low to zero carbon technologies. Infrastructure projects related to transit systems, including rolling stocks and signalling. Establishment or modification of appropriate regulations regarding public transportation.

Regulations, directives and policies developed under the Pest Control Products Act in regard to equipment and potential operator exposure. Amendments to the Income Tax Act and Regulations which may affect agriculture and the tax treatment of capital expenditures on equipment. Amendments to the Copyright Act and Regulations which may affect the service and operation of agriculture and construction equipment. Discussions with officials regarding labour training opportunities for skilled workforce in the agriculture and construction equipment sectors. Ongoing discussions with federal officials regarding Canada-US bilateral trade of construction, forestry, mining and agriculture equipment under the terms of the Canada-United States-Mexico Agreement (CUSMA). Regulations, directives, and policies developed in regard to the off-road equipment sector.

Public health and prevention programs including the Public Health Agency of Canada and efforts to support the development and procurement of innovative vaccines and therapies to address major public health issues such as pandemic preparedness and RSV Federally-funded public drug plans, including the Non-Insured Health Benefits program, Canadian Armed Forces Drug Benefit List and veteran programs, with respect to reimbursement for drug products for beneficiaries Canada's Drug Agency policies and processes as it relates to reimbursement recommendation decision-making process and framework Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry, as well as free trade agreements as they relate to the biopharmaceutical industry Establish accountability with Health Canada, Canada’s Drug Agency and the pan-Canadian Pharmaceutical Alliance, as well as Regulations, policies and programs related to the review and reimbursement processes Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products Policy measures to ensure security of drug supply in Canada and preserve Canada’s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB) Engagement with the Government regarding the Strategic Response Fund (SRF) (previously known as SIF) and investment in Canada Annual federal Budgets and Budget updates relating to the biopharmaceutical industry. Scientific Research and Experimental Development (SR&ED) Tax Incentive Program regarding eligible expenditures. Discussions on policies such as "patent box" and Investment Tax Credits.